| Characteristics |
Without HAART
(n=100) |
With HAART
(n=255) |
p value |
Gender n (%)
Female
Male |
52 (52.0%)
48 (48.0%) |
122 (47.8%)
133 (52.2%) |
0.4810 |
Ethnicity n (%)
Caucasian
No Caucasian |
67 (67.0%)
33 (33.0%) |
141(55.3%)
114 (44.7%) |
0.0440 |
| Age (years) |
32.0 (26.0-42.0) |
42.0 (36.0-48.0) |
<0.0001 |
| Body mass index (Kg/cm2) |
24.4 (21.3-26.9) |
24.2 (21.5-27.2) |
0.9872 |
| Waist circumference (cm) |
89.0 (80.3-96.0) |
90.0 (84.0-98.0) |
0.1714 |
| Triglycerides (mg/dL) |
119.5 (78.8-160.8) |
167.0 (105.0-229.0) |
<0.0001 |
| Total cholesterol (mg/dL) |
175.0 (152.3-193.5) |
207.0 (168.0-246.0) |
<0.0001 |
| LDL- cholesterol (mg/dL) |
102.9 (86.3-127.5) |
124.2 (93.0-152.0) |
0.0003 |
| HDL- cholesterol (mg/dL) |
42.5 (35.0-49.8) |
43.0 (38.0-52.0) |
0.2042 |
| TCD3+ lymphocyte (cells/µL) |
1466 (939-2014) |
1627 (1222-2036) |
0.3673 |
| TCD4+ lymphocyte (cells/µL) |
407 (195-667) |
482 (300-669) |
0.2849 |
| TCD8+ lymphocyte (cells/µL) |
936 (586-1239) |
1027 (748-1331) |
0.2238 |
| TCD4+/TCD8+ ratio |
0.36 (0.21-0.74) |
0.49 (0.29-0.68) |
0.2689 |
| HIV-1 Viral load (copies/mL) |
24990 (3377-94890) |
<50 |
<0.0001 |
| HIV-1 Viral load (log10/mL) |
4.35 (3.40-4.90) |
<1.70 |
<0.0001 |
|
| Chi-square test with Yates’ correction. Mann-Whitney test. Data are expressed median (25%-75%). HAART: highly active antiretroviral therapy; LDL-C: low- density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol |
| Table 1: Demographic, anthropometric, and biochemical characteristics of human immunodeficiency type 1 (HIV-1)-infected patients from Southern Brazil, according to the therapy. |
